Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

NAD dismisses Zicam case

This article was originally published in The Tan Sheet

Executive Summary

Quigley's use of Gel Tech's submissions to NAD as evidence in its federal court proceeding against Zicam has caused the Council of Better Business Bureaus' National Advertising Division to close its review of Gel Tech's ad claims for Zicam Cold Remedy without issuing a decision. Quigley, the marketer of Cold-Eeze lozenges and challenger of the Zicam claims, violated their confidentiality agreement through its actions, NAD says (1"The Tan Sheet" April 24, p. 8). NAD notes it had "concerns" about whether the claims, including "highly effective cold remedy" and "reduce the duration of the common cold," were adequately supported
Advertisement

Related Content

Topics

Advertisement
UsernamePublicRestriction

Register

PS091213

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel